Curaleaf Holdings (CURLF) Share-based Compensation (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Share-based Compensation of -$20.4 million for Q4 2024, down 449.26% year-on-year from $5.8 million in Q1 2024, and down 438.52% on a QoQ basis from $6.0 million in Q3 2024.

Curaleaf Holdings (CURLF) Share-based Compensation (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Share-based Compensation for 6 consecutive years, with -$20.4 million the latest figure, recorded in Q4 2024.

  • Quarterly Share-based Compensation fell 449.26% year-over-year to -$20.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$2.3 million (down 138.81% YoY) and the FY2025 annual result came in at $35.7 million, changed N/A from the prior year.
  • Share-based Compensation retreated to -$20.4 million in Q4 2024 per CURLF's latest filing, from $6.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for CURLF reached as high as $18.4 million in Q2 2021 and fell as low as -$20.4 million in Q4 2024.
  • A 5-year average of $4.5 million and a median of $5.9 million in 2023 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2021 — Share-based Compensation surged 189.25% — and 2022, when it slumped 633.27%.
  • Year by year, Share-based Compensation stood at $13.1 million in 2020, then slumped by 76.88% to $3.0 million in 2021, then sank by 633.27% to -$16.1 million in 2022, then jumped by 136.17% to $5.8 million in 2023, then tumbled by 449.26% to -$20.4 million in 2024.
  • According to Business Quant data, Share-based Compensation over the past three periods registered -$20.4 million, $6.0 million, and $5.8 million for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -20.37 Mn
Dec 31, 2024 -20.37 Mn
Sep 30, 2024 6.02 Mn
Sep 30, 2024 6.02 Mn
Dec 31, 2023 5.83 Mn
Dec 31, 2023 5.83 Mn
Sep 30, 2023 6.22 Mn
Sep 30, 2023 6.22 Mn
Dec 31, 2022 -16.13 Mn
Dec 31, 2022 -16.13 Mn
Sep 30, 2022 9.99 Mn
Sep 30, 2022 9.99 Mn
Jun 30, 2022 6.04 Mn
Jun 30, 2022 6.04 Mn
Mar 31, 2022 5.09 Mn
Mar 31, 2022 5.09 Mn
Dec 31, 2021 3.02 Mn
Dec 31, 2021 3.02 Mn
Sep 30, 2021 13.18 Mn
Sep 30, 2021 13.18 Mn